Pharmaceutical Companies Eye India
On May 21, Abbott Laboratories announced that it would purchase Piramal Healthcare, a branded generics company based in India, for $3.72 billion.
feature2
Not a Drop to Drink
As we brush our teeth, take our long showers, and drink our eight glasses a day, it’s easy to forget that nearly one billion people in the world don’t have access to clean water.
[Company Profile] Altea Therapeutics
One of the more impressive companies at the IN3 West conference was Altea Therapeutics, an Atlanta-based clinical stage company involved in drug delivery.
New National Drug Abuse Strategy Emphasizes Prevention
On May 11, the Obama administration unveiled its 2010 National Drug Control Strategy to reduce illicit drug use in America.
[Company Profile] NeoVista
The company is focused on the development of medical technologies that to treat wet age-related macular degeneration (AMD).
FDA Hopes to Keep Pharma Honest With “Bad Ad” Program
Last week, the FDA unveiled its “Bad Ad” program to encourage physicians to report questionable pharmaceutical sales pitches.
OneMedForum to Cover Translational Research, European Market
A dedicated company presentation track for regional Translational Research will be presented at the June 30th OneMedForum at the Roosevelt Hotel in midtown Manhattan.
Inhalable Drugs Let Patients Take a Breather from Needles
Earlier this month, a team of researchers led by the University of Colorado at Boulder announced that the inhalable measles vaccine they developed could lead to vaccines for other diseases.
E. Coli-Tainted Lettuce Highlights Food Contamination Problem
Tennessee became the fourth state to be hit by the E. coli outbreak caused by tainted Romaine lettuce, USA Today reported on Thursday.
Look Ma, No Pain: Treating Asymptomatic Patients
It’s not hard to convince a patient who is in pain to take his or her medication, but what about the patient who doesn’t feel any symptoms?